UTI w/ Antibiotic Resistance
Molecular microbiology identifies microorganisms including bacteria, fungi and viruses through DNA detection. This technique is very sensitive, specific, and rapid compared to traditional microbiology procedures, creating a powerful diagnostic tool for physicians.
Our profile delivers a snapshot of a patient’s urinary tract micro-environment covering 28 pathogens and 8 antibiotic resistance markers. Meridian’s scientific team utilizes
cutting-edge technology to detect pathogenic and nonpathogenic bacterial species. Additionally, the test also defines the genes associated with antibiotic resistance.
UTI w/ Antibiotic Resistance
UTIs account for more than 8 million healthcare visits and 100,000 hospitalizations each year. Overall expenditures for UTIs in the U.S. are estimated to be $3.4 billion. Much of this is due to the slow turn around time of the traditional culture and the fact that it misses up to two-thirds of all positive UTIs.
UTI Plus Panel | |
---|---|
• Acinetobacter baumannii | • Klebsiella pneumoniae |
• Bacteroides fragilis | • Morganella morganii |
• Candida albicans | • Mycoplasma genitalium |
• Candida dubliniensis | • Mycoplasma hominis |
• Candida glabrata | • Prevotella bivia |
• Candida krusei | • Proteus mirabilis |
• Candida parapsilosis | • Pseudomonas aeruginosa |
• Candida tropicalis | • Serratia marcescens |
• Citrobacter braakii/freundii | • Staphylococcus aureus |
• Citrobacter koseri | • Staphylococcus epidermidis |
• Enterobacter cloacae | • Staphylococcus saprophyticus |
• Enterococcus spp. | • Streptococcus agalactiae (Group B) |
• Escherichia coli | • Streptococcus pyogenes (Group A) |
• Klebsiella aerogenes | • Ureaplasma urealyticum |
Antibiotic resistance can be identified for the following classes of antibiotics:
ABX Resistance Markers
- Class A Beta-lactamase (blaKPC)
- Class A Beta-lactamase (CTX-M-Group 1)
- Class B metallo Beta-lactamase (blaNDM)
- Vancomycin
- Methicillin/Oxacillin
- Sulfonamides
- Fluoroquinolones
- Trimethoprim